US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

JPMORGAN HEALTHCARE LEADERS ETF

62.56

-0.0350-0.06%

Volume:273

Turnover:17.23K

Market Cap:9.38M

PE:- -

High:63.00

Open:63.00

Low:62.56

Close:62.60

52wk High:64.69

52wk Low:50.34

Shares:150.00K

Float Shares:150.00K

Volume Ratio:0.55

T/O Rate:0.18%

Dividend:0.51

Dividend Rate:0.82%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Ajinomoto Advances Major Share Buyback, Plans Cancellation of Repurchased Stock

Aptabio Therapeutics Plans Seoul NDR to Deepen R&D Dialogue with Institutions

Merck (MRK) Wins FDA Approval For First Oral PCSK9 Cholesterol Drug

Simply Wall St.

Johnson & Johnson EVP Thomas Cavanaugh Files Initial Beneficial Ownership Statement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/JDOC"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JDOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JDOC\",,,,,undefined,":{"symbol":"JDOC","market":"US","secType":"STK","nameCN":"JPMORGAN HEALTHCARE LEADERS ETF","latestPrice":62.5624,"timestamp":1788292800000,"preClose":62.5974,"halted":0,"volume":273,"delay":0,"changeRate":-0.0005591286539058123,"floatShares":150000,"shares":150000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.035,"latestTime":"09-02 05:53:03 EDT","open":63,"high":63,"low":62.5624,"amount":17232,"amplitude":0.006991,"askPrice":99.47,"askSize":100,"bidPrice":25.15,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":62.5624,"sharesOutstanding":150000,"nav":62.39,"aum":9358517.28,"dividendRate":0.008205,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":63,"preClose":62.5624,"latestTime":"16:10 EDT","volume":6,"amount":375.3696,"timestamp":1788293404350,"change":0.4376,"changeRate":0.006995,"amplitude":0},"volumeRatio":0.5526314335180438},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JDOC\",,,,,undefined,":{"symbol":"JDOC","floatShares":150000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5526314335180438,"shares":150000,"dividePrice":0.5133,"high":63,"amplitude":0.006991,"preClose":62.5974,"low":62.5624,"week52Low":50.34,"pbRate":"--","week52High":64.69,"institutionHeld":0,"latestPrice":62.5624,"eps":0,"divideRate":0.008205,"volume":273,"delay":0,"ttmEps":0,"open":63,"prevYearClose":57.9058,"prevWeekClose":62.7705,"prevMonthClose":62.5974,"prevQuarterClose":60.2303,"fiveDayClose":64.664,"twentyDayClose":60.1817,"sixtyDayClose":56.9274},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JDOC\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"JDOC","amount":0.5121,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-18","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-18"},{"date":"2024-12-24","symbol":"JDOC","amount":0.3276,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-27"},{"date":"2024-12-16","symbol":"JDOC","amount":2.48902,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-18"},{"date":"2023-12-19","symbol":"JDOC","amount":0.07965,"announcedDate":"2023-12-18","type":"dividend","market":"US","newRecordDate":"2023-12-20","defaultRemindTime":1702996200000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","recordDate":"2023-12-22","payableDate":"2023-12-20","currency":"USD","dateTimestamp":1702962000000,"payDate":"2023-12-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JDOC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-19","recordDate":"2023-12-20","paymentDate":"2023-12-22","value":0.07965,"currency":"USD"},{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-18","value":2.48902,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-27","value":0.3276,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-18","value":0.5121,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JDOC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JDOC\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664891664","title":"Ajinomoto Advances Major Share Buyback, Plans Cancellation of Repurchased Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891664","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891664?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:53","pubTimestamp":1788331999,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Ajinomoto Co ( ($JP:2802) ). Ajinomoto Co., Inc., a leading Japanese food and biotechnology group listed on the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ajinomoto-advances-major-share-buyback-plans-cancellation-of-repurchased-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ajinomoto-advances-major-share-buyback-plans-cancellation-of-repurchased-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4585","BK4588","XT","LNGR","AGNG","JDOC","BBP","IEIH","DARP","FHLC","SYNB","FWD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664997828","title":"Aptabio Therapeutics Plans Seoul NDR to Deepen R&D Dialogue with Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2664997828","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664997828?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:21","pubTimestamp":1788330080,"startTime":"0","endTime":"0","summary":"Aptabio Therapeutics, Inc. ( ($KR:293780) ) has provided an update. Aptabio Therapeutics, Inc., a biotechnology company focused on research and dev...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aptabio-therapeutics-plans-seoul-ndr-to-deepen-rd-dialogue-with-institutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aptabio-therapeutics-plans-seoul-ndr-to-deepen-rd-dialogue-with-institutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4585","FHLC","FWD","BK4588","IEIH","BK4007","JDOC","LNGR","XT","BK4139","AGNG","DARP","RSPH","IBB","BK4539","SYNB","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664620778","title":"Merck (MRK) Wins FDA Approval For First Oral PCSK9 Cholesterol Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664620778","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664620778?lang=en_us&edition=fundamental","pubTime":"2026-09-02 08:26","pubTimestamp":1788308809,"startTime":"0","endTime":"0","summary":"Merck (NYSE:MRK) has received US FDA approval for LIPFENDRA, the first oral PCSK9 inhibitor for cholesterol management.\nThe drug targets adults with hypercholesterolemia who need additional LDL cholesterol lowering beyond existing therapies.\nLIPFENDRA introduces an oral option in a treatment class that has so far been dominated by injectable PCSK9 therapies.\n\nThis shift toward oral and AI supported drug development in cardiometabolic care points to a broader trend that investors may want to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/288502-main-header/1756255043815","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/288502-main-header/1756255043815"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mrk/merck/news/merck-mrk-wins-fda-approval-for-first-oral-pcsk9-cholesterol","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mrk/merck/news/merck-mrk-wins-fda-approval-for-first-oral-pcsk9-cholesterol","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B1BXHZ80.USD","LU0289739699.SGD","LU0203347892.USD","LU1057294990.SGD","BK4588","LU1093756325.SGD","LU0130102774.USD","LU2112291526.USD","LU0122379950.USD","LU0985320562.USD","LU1929549753.HKD","LU1430594728.SGD","LU1069347547.HKD","LU0965508806.USD","LU0648001328.SGD","LU2125909593.SGD","IHE","BK4516","LU0006306889.USD","LU0859254822.USD","SG9999014559.SGD","LU1699723380.USD","PPH","LU2361044865.SGD","IE00BBT3K403.USD","BK4559","LU1983299246.USD","LU0868494708.USD","VHT","LU2125154935.USD","SG9999013999.USD","LU0130517989.USD","LU0689626769.HKD","LU1066051225.USD","FTXH","SG9999001176.SGD","LU0070302665.USD","LU1291159041.SGD","IE0002141913.USD","LU0965509283.SGD","LU1023059063.AUD","LU1066051811.HKD","IE00B4R5TH58.HKD","SG9999015341.SGD","SG9999001176.USD","SG9999014542.SGD","LU2491049909.HKD","LU2360032135.SGD","LU2361044949.HKD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU1116320737.USD","LU0868494617.USD","SG9999015358.SGD","LU0238689110.USD","LU0234572021.USD","LU2357627491.SGD","LU1585245621.USD","LU1571399168.USD","LU2361045086.USD","LU0965509010.AUD","LU0477156953.USD","LU0861579265.USD","LU0266013472.USD","LU0265550946.USD","FHLC","LU2491050154.USD","LU0106261372.USD","SG9999001440.SGD","LU1035773651.USD","LU1974910355.USD","LU1037948897.HKD","SG9999002232.USD","LU2106854487.HKD","PAWZ","LU2491050071.SGD","LU2023250843.SGD","LU1917777945.USD","LU1941712264.USD","BK4533","LU0265550359.USD","LU2468319806.SGD","BK4585","LU1066053197.SGD","LU1061106388.HKD","LU2433249047.HKD","LU0432979614.USD","IE00BJJMRZ35.SGD","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU1923622614.USD","RXL","LU2324357040.USD","LU0211331839.USD","LU0980610538.SGD","SG9999014567.USD","IE00BSNM7G36.USD","BK4007","GDOC","LU0320765489.SGD","BK4550","LU0124676726.USD","IE0009355771.USD","IE00BLSP4452.SGD","LU0098860793.USD","XLV","BK4534","LU2125909247.SGD","LU2125154778.USD","JDOC","LU1989772923.USD","LU0203345920.USD","SG9999002224.SGD","LU2089984988.USD","MRK","LU1116320901.HKD","LU0823416689.USD","LU1093756168.USD","LU1934455863.HKD","IE00B2B36J28.USD","LU0320765646.SGD","LU1934455194.USD","LU1989771016.USD","SGXZ57979304.SGD","IXJ","LU1934455277.USD","LU1032466523.USD","LU0208291251.USD","LU1066051498.USD","LU1941712348.USD","LU1037948541.HKD","LU2461242641.AUD","HRTS","LU1201861249.SGD","IE00BN8TJ469.HKD","IYH","LU1989772840.SGD","LU0942090050.USD","SG9999014575.USD","LU0058720904.USD","LU1162221912.USD","LU2023250504.SGD","TRUH","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386900","title":"Johnson & Johnson EVP Thomas Cavanaugh Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386900","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386900?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:53","pubTimestamp":1788295990,"startTime":"0","endTime":"0","summary":"Johnson & Johnson EVP Thomas Cavanaugh files initial beneficial ownership statementJohnson & Johnson EVP WW Chair, Innovative Med. Thomas Cavanaugh filed a Form 3 disclosing 499 common shares, includi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL58rn8Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0964807845.USD","TRUH","FTXH","IE00BVYPNW00.USD","LU1732800096.USD","LU1430594728.SGD","RXL","GDOC","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0943347566.SGD","VHT","BK4504","IE00BKVL7J92.USD","LU1221951046.USD","LU1032466523.USD","LU0994945656.USD","IE000WAW04H5.SGD","LU1496350502.SGD","LU2602419157.SGD","LU2430703251.USD","LU2213496289.HKD","IHE","SG9999013999.USD","LU2112291526.USD","LU2487616109.SGD","JDOC","IE000F7OJYX1.SGD","IXJ","IE00B19Z3581.USD","FHLC","LU0289739699.SGD","IE00BSNM7G36.USD","LU0545562505.USD","XLV","LU1929549753.HKD","LU2750360997.AUD","JNJ","BMED","LU2133065610.SGD","LU0234572021.USD","IYH","MEDX","IE00BLSP4452.SGD","IE00BVYPNV92.GBP","LU1228905540.USD","LU0689472784.USD","BK4568","LU0203347892.USD","PJP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":70,"pageCount":1,"totalSize":278,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/JDOC\",params:#limit:6,delay:false,,,undefined,":[]}}